BetterLife Pharma Inc.
BETR
CNSX
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.75% | 15.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.68% | 12.44% | |||
| Operating Income | 24.68% | -12.44% | |||
| Income Before Tax | 17.47% | -151.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.47% | -151.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 14.29% | 325.81% | |||
| Net Income | 18.09% | -141.87% | |||
| EBIT | 24.68% | -12.44% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 20.83% | -118.18% | |||
| Normalized Basic EPS | 20.00% | -25.00% | |||
| EPS Diluted | 8.33% | -71.43% | |||
| Normalized Diluted EPS | 20.00% | -25.00% | |||
| Average Basic Shares Outstanding | 1.44% | 15.07% | |||
| Average Diluted Shares Outstanding | 1.44% | 15.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||